WealthShield Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.17M | Buy |
5,384
+5
| +0.1% | +$1.11K | 0.13% | 170 |
|
|
2025
Q4 | $1.23M | Buy |
5,379
+626
| +13% | +$143K | 0.14% | 156 |
|
|
2025
Q3 | $1.1M | Sell |
4,753
-92
| -2% | -$18.7K | 0.12% | 167 |
|
|
2025
Q2 | $899K | Sell |
4,845
-119
| -2% | -$22.1K | 0.11% | 180 |
|
|
2025
Q1 | $1.04M | Buy |
4,964
+373
| +8% | +$72.5K | 0.13% | 157 |
|
|
2024
Q4 | $816K | Sell |
4,591
-202
| -4% | -$37.1K | 0.12% | 173 |
|
|
2024
Q3 | $947K | Buy |
4,793
+163
| +4% | +$30.4K | 0.13% | 162 |
|
|
2024
Q2 | $794K | Buy |
4,630
+208
| +5% | +$34.5K | 0.12% | 165 |
|
|
2024
Q1 | $805K | Sell |
4,422
-250
| -5% | -$43.1K | 0.13% | 162 |
|
|
2023
Q4 | $724K | Sell |
4,672
-176
| -4% | -$25.7K | 0.12% | 171 |
|
|
2023
Q3 | $723K | Buy |
4,848
+281
| +6% | +$41.3K | 0.11% | 178 |
|
|
2023
Q2 | $615K | Sell |
4,567
-464
| -9% | -$68K | 0.09% | 192 |
|
|
2023
Q1 | $802K | Sell |
5,031
-425
| -8% | -$65K | 0.13% | 169 |
|
|
2022
Q4 | $882K | Sell |
5,456
-126
| -2% | -$19.3K | 0.17% | 144 |
|
|
2022
Q3 | $749K | Buy |
5,582
+45
| +0.8% | +$6.46K | 0.15% | 160 |
|
|
2022
Q2 | $848K | Buy |
5,537
+165
| +3% | +$25.2K | 0.17% | 148 |
|
|
2022
Q1 | $871K | Sell |
5,372
-1,047
| -16% | -$152K | 0.14% | 162 |
|
|
2021
Q4 | $869K | Buy |
6,419
+3,385
| +112% | +$400K | 0.14% | 151 |
|
|
2021
Q3 | $327K | Sell |
3,034
-1,971
| -39% | -$225K | 0.09% | 183 |
|
|
2021
Q2 | $564K | Buy |
5,005
+448
| +10% | +$50.5K | 0.09% | 157 |
|
|
2021
Q1 | $493K | Sell |
4,557
-1,866
| -29% | -$200K | 0.09% | 160 |
|
|
2020
Q4 | $688K | Sell |
6,423
-574
| -8% | -$55.2K | 0.13% | 132 |
|
|
2020
Q3 | $613K | Buy |
6,997
+2,069
| +42% | +$195K | 0.21% | 106 |
|
|
2020
Q2 | $484K | Sell |
4,928
-1,476
| -23% | -$130K | 0.22% | 105 |
|
|
2020
Q1 | $488K | Buy |
+6,404
| New | +$545K | 0.3% | 75 |
|
|
2019
Q2 | – | Sell |
-3,738
| Closed | -$301K | – | 223 |
|
|
2019
Q1 | $301K | Buy |
3,738
+603
| +19% | +$49.3K | 0.17% | 105 |
|
|
2018
Q4 | $289K | Sell |
3,135
-461
| -13% | -$40.5K | 0.2% | 92 |
|
|
2018
Q3 | $340K | Sell |
3,596
-96
| -3% | -$9.1K | 0.19% | 83 |
|
|
2018
Q2 | $342K | Sell |
3,692
-85
| -2% | -$8.3K | 0.21% | 78 |
|
|
2018
Q1 | $357K | Sell |
3,777
-361
| -9% | -$39.7K | 0.23% | 75 |
|
|
2017
Q4 | $406K | Buy |
+4,138
| New | +$390K | 0.25% | 77 |
|
Other funds holding ABBV
VCM
VPM
WealthShield Partners's ABBV Position: Q1 2026 in Review
WealthShield Partners increased its AbbVie (ABBV) stake by 0.09% in Q1 2026, buying an estimated $1.11K and bringing the position to 5,384 shares worth $1.17M. The position accounts for 0.13% of the portfolio, ranked #170.
WealthShield Partners first reported a position in ABBV in Q4 2017 and has held it in 31 quarters since. The position peaked at $1.23M in Q4 2025. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- WealthShield Partners held 5,384 shares of AbbVie worth $1.17M as of Q1 2026.
- WealthShield Partners bought 5 AbbVie shares in Q1 2026, an estimated $1.11K.
- AbbVie made up 0.13% of WealthShield Partners's portfolio in Q1 2026, its #170 holding.
- WealthShield Partners first reported a position in AbbVie in Q4 2017 and has held it in 31 quarters since.
- WealthShield Partners's AbbVie position peaked at $1.23M in Q4 2025.
- 4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on WealthShield Partners's 13F filing for Q1 2026, filed 1 May 2026.